Riskpilot← Back to searchSign inGet full accessOPITEK INTERNATIONAL ApS
APSActiveCVR 30554582Gøngehusvej 252Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20071 employeeswww.opitek-international.dk
Revenue 2024
DKK 1,5M
+34% vs 2023
EBITDA margin
74.5%
-1% vs 2023
Equity ratio
80.2%
Financial strength
Net profit 2024
DKK 843K
+2% vs 2023
| Revenue | DKK 1,5M | +34% |
| EBITDA | DKK 1,1M | -1% |
| Net profit | DKK 843K | +2% |
| Total assets | DKK 4,9M | +5% |
| Equity | DKK 3,9M | +21% |
| Employees | 1 | — |
Legal name
OPITEK INTERNATIONAL ApS
CVR number
30554582
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
29. juni 2007
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening
Company purpose
Selskabets formål er drive handel med medicotekniske produkter og ydelser og dermed beslægtede forretningsområder, direkte eller indirekte ved besiddelse af kapitalandel i et selskab, der handler med sådanne produkter.
Address
Gøngehusvej 252
Phone
+4539661644
Email
info@opitek.dk
Website
www.opitek-international.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50 | 82 | 121 | 198 | 191 | 241 | 162 | 418 | 354 | 867 | 1.003 | 1.113 | 1.487 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -380 |
| EBITDA | 50 | 82 | 121 | 198 | 191 | 241 | 162 | 418 | 354 | 867 | 1.003 | 1.113 | 1.107 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 50 | 82 | 121 | 198 | 191 | 241 | 162 | 418 | 354 | 867 | 1.003 | 1.113 | 1.107 |
| Net financials | -31 | -2 | -3 | -29 | -18 | -58 | -14 | -45 | 52 | -31 | -23 | -25 | -18 |
| Profit before tax | 20 | 81 | 118 | 169 | 173 | 183 | 148 | 373 | 407 | 835 | 980 | 1.088 | 1.090 |
| Tax | 5 | 20 | 29 | 41 | 38 | 17 | 11 | 85 | 95 | 193 | 221 | 259 | 247 |
| Net profit | 15 | 60 | 89 | 128 | 135 | 165 | 137 | 287 | 311 | 643 | 759 | 829 | 843 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.519 | 2.659 | 3.324 | 4.330 | 4.289 | 4.998 | 4.436 | 5.716 | 7.466 | 2.917 | 3.641 | 4.664 | 4.904 |
| Equity | 297 | 357 | 446 | 575 | 709 | 874 | 1.012 | 1.299 | 1.461 | 1.953 | 2.562 | 3.241 | 3.934 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.222 | 2.302 | 2.878 | 3.755 | 3.580 | 4.124 | 3.424 | 4.417 | 6.005 | 964 | 1.080 | 1.423 | 970 |
| Total debt | 2.222 | 2.302 | 2.878 | 3.755 | 3.580 | 4.124 | 3.424 | 4.417 | 6.005 | 964 | 1.080 | 1.423 | 970 |
EBITDA margin
74.5%
This company
15.8%
Market median
+372% vs market
20122024
Equity ratio
80.2%
This company
38.2%
Market median
+110% vs market
20122024
Return on equity
21.4%
This company
18.4%
Market median
+16% vs market
20122024
Net profit margin
56.7%
This company
8.1%
Market median
+600% vs market
20122024
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20122024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AM Management | Management | 2020 | — | — |
KP Chief Executive Officer | Chief Executive Officer | 2007 | — | — |
RH Management | Management | 2025 | — | — |
JO Management | Management | 2025 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OPITEK INTERNATIONAL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Minor Christensen | Management | 0 companies |
| Kim Peter Christensen | Chief Executive Officer | 0 companies |
| Rolf Ho Bornschein | Management | 0 companies |
| Johan Olof Mårten Bongstorp | Management | 0 companies |